Interaction between α-Synuclein and Other Proteins in Neurodegenerative Disorders

被引:57
|
作者
Jellinger, Kurt A. [1 ]
机构
[1] Inst Clin Neurobiol, A-1070 Vienna, Austria
来源
THESCIENTIFICWORLDJOURNAL | 2011年 / 11卷
关键词
neurodegeneration; alzheimer disease; parkinson disease; protein interaction; coformer seeding; pathogenesis; BETA-AMYLOID PEPTIDES; SPORADIC PARKINSONS-DISEASE; MULTIPLE SYSTEM ATROPHY; AMYGDALA LEWY BODIES; TAU-TRANSGENIC MICE; ALZHEIMERS-DISEASE; A-BETA; MOUSE MODEL; EXTRAPYRAMIDAL SIGNS; ANIMAL-MODELS;
D O I
10.1100/2011/371893
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Protein aggregation is a common characteristic of many neurodegenerative disorders, and the interaction between pathological/toxic proteins to cause neurodegeneration is a hot topic of current neuroscience research. Despite clinical, genetic, and experimental differences, evidence increasingly indicates considerable overlap between synucleinopathies and tauopathies or other protein-misfolding diseases. Inclusions, characteristics of these disorders, also occurring in other neurodegenerative diseases, suggest interactions of pathological proteins engaging common downstream pathways. Novel findings that have shifted our understanding in the role of pathologic proteins in the pathogenesis of Parkinson and Alzheimer diseases have confirmed correlations/overlaps between these and other neurodegenerative disorders. The synergistic effects of alpha-synuclein, hyperphosphorylated tau, amyloid-beta, and other pathologic proteins, and the underlying molecular pathogenic mechanisms, including induction and spread of protein aggregates, are critically reviewed, suggesting a dualism or triad of neurodegeneration in protein-misfolding disorders, although the etiology of most of these processes is still mysterious.
引用
收藏
页码:1893 / 1907
页数:15
相关论文
共 50 条
  • [41] Heat shock proteins in neurodegenerative disorders and aging
    Rehana K. Leak
    Journal of Cell Communication and Signaling, 2014, 8 : 293 - 310
  • [42] Zeroing in on neurodegenerative α-synuclein
    Katie Kingwell
    Nature Reviews Drug Discovery, 2017, 16 : 371 - 373
  • [43] Zeroing in on neurodegenerative α-synuclein
    Kingwell, Katie
    NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (06) : 371 - U85
  • [44] Fatal attractions of proteins - A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders
    Trojanowski, JQ
    Lee, VMY
    ALZEHEIMER'S DISEASE: A COMPENDIUM OF CURRENT THEORIES, 2000, 924 : 62 - 67
  • [45] Quantitative Interaction Proteomics of Neurodegenerative Disease Proteins
    Hosp, Fabian
    Vossfeldt, Hannes
    Heinig, Matthias
    Vasiljevic, Djordje
    Arumughan, Anup
    Wyler, Emanuel
    Landthaler, Markus
    Hubner, Norbert
    Wanker, Erich E.
    Lannfelt, Lars
    Ingelsson, Martin
    Lalowski, Maciej
    Voigt, Aaron
    Selbach, Matthias
    CELL REPORTS, 2015, 11 (07): : 1134 - 1146
  • [46] Interaction between intrinsically disordered proteins Praja1 and α-synuclein on gold electrodes
    Mori, Wataru
    Onodera, Wataru
    Kojima, Terutoshi
    Asahi, Toru
    Nakanishi, Takuya
    CHEMISTRY LETTERS, 2024, 53 (11)
  • [47] INTERACTION BETWEEN NUCLEIC ACIDS HISTONES AND OTHER PROTEINS IN AGAROSE
    GURVICH, AE
    GORODETS.SI
    SIDOROVA, EV
    BIOCHEMISTRY-MOSCOW, 1967, 32 (2P1) : 251 - &
  • [48] INTERACTION BETWEEN NUCLEIC ACIDS HISTONES AND OTHER PROTEINS IN AGAROSE
    GURVICH, AE
    GORODETS.SI
    SIDOROVA, EV
    BIOCHIMICA ET BIOPHYSICA ACTA, 1967, 138 (03) : 499 - +
  • [49] β-synuclein-derived peptides with neuroprotective activityAn alternative treatment of neurodegenerative disorders?
    Manfred Windisch
    Birgit Hutter-Paier
    Edith Schreiner
    Robert Wronski
    Journal of Molecular Neuroscience, 2004, 24 : 155 - 165
  • [50] Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders
    Elvira Valera
    Brian Spencer
    Eliezer Masliah
    Neurotherapeutics, 2016, 13 : 179 - 189